Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Fisher, Elliott S.
2020.
Reforming Health Care: The Single System Solution.
NEJM Catalyst,
Vol. 1,
Issue. 5,
Van de Wiele, Victor L.
Kesselheim, Aaron S.
and
Sarpatwari, Ameet
2021.
Barriers To US Biosimilar Market Growth: Lessons From Biosimilar Patent Litigation.
Health Affairs,
Vol. 40,
Issue. 8,
p.
1198.
Feldman, William B.
Bloomfield, Doni
Beall, Reed F.
and
Kesselheim, Aaron S.
2022.
Brand-name market exclusivity for nebulizer therapy to treat asthma and COPD.
Nature Biotechnology,
Vol. 40,
Issue. 9,
p.
1319.
White, Joseph
and
Corwin, Nicholas
2022.
Insulin Shocks.
Journal of Health Politics, Policy and Law,
Vol. 47,
Issue. 6,
p.
731.
Dusetzina, Stacie B.
and
Oberlander, Jonathan
2022.
The Price of Progress: Managing Prescription Drug Spending.
Journal of Health Politics, Policy and Law,
Vol. 47,
Issue. 6,
p.
621.
Feldman, Robin
Fulton, Brent
Godwin, Jamie
and
Scheffler, Richard M
2022.
Challenges with Defining Pharmaceutical Markets and Potential Remedies to Screen for Industry Consolidation.
SSRN Electronic Journal,
Collington, Rosie
and
Lazonick, William
2022.
Van de Wiele, Victor L.
Beall, Reed F.
Kesselheim, Aaron S.
and
Sarpatwari, Ameet
2022.
The characteristics of patents impacting availability of biosimilars.
Nature Biotechnology,
Vol. 40,
Issue. 1,
p.
22.
Feldman, Robin
Fulton, Brent D.
Godwin, Jamie R.
and
Scheffler, Richard M.
2022.
Challenges with Defining Pharmaceutical Markets and Potential Remedies to Screen for Industry Consolidation.
Journal of Health Politics, Policy and Law,
Vol. 47,
Issue. 5,
p.
583.
Feldman, William B.
Bloomfield, Doni
Beall, Reed F.
and
Kesselheim, Aaron S.
2022.
Patents And Regulatory Exclusivities On Inhalers For Asthma And COPD, 1986–2020.
Health Affairs,
Vol. 41,
Issue. 6,
p.
787.
Reddy, Sanjay
Beall, Reed F.
Tu, S. Sean
Kesselheim, Aaron S.
and
Feldman, William B.
2023.
Patent Challenges And Litigation On Inhalers For Asthma And COPD.
Health Affairs,
Vol. 42,
Issue. 3,
p.
398.
Feldman, Robin
2023.
CalRx Biosimilar Insulin: California’s Initiative to Enter the Insulin Market.
JAMA Internal Medicine,
Vol. 183,
Issue. 10,
p.
1043.
Strohbehn, Garth W.
Lichter, Allen S.
and
Ratain, Mark J.
2023.
US Government Payer–Funded Trials to Address Oncology's Drug-Dosing Conundrum: A Congressional Call to Action?.
Journal of Clinical Oncology,
Vol. 41,
Issue. 14,
p.
2488.